Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CINVAROM: Inhaled Aromatherapy for Chemo-Induced Nausea and Vomiting
NCT04560114Phase 2Completed
- Sponsor
- Centre François Baclesse
- Start
- Dec 2020
- Primary completion
- Sep 2021
- Modality
- NPI (Non-Pharmacological Intervention), Nutraceutical
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in chemotherapy-induced nausea and vomiting (CINV), sponsored by Centre François Baclesse. Primary endpoint: Number of Episodes of Nausea and Vomiting at 5 days. Started Dec 2020; status: completed.
02
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04560114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04560114.